Haviv Ilan

Haviv Ilan is chairman, president and chief executive officer of Texas Instruments. His operating challenge is to turn a long manufacturing investment program into competitive products, useful capacity and sustained cash generation.

Haviv Ilan

1. Business Role

Ilan coordinates three operating horizons. Current execution concerns customers, production and expenses. Product development concerns designs that may ship later. Factory investment concerns assets whose useful life can span many equipment programs.

The question is how those horizons work together. Capacity without competitive products can remain underused; design wins without qualified supply can disappoint customers. The CEO's leverage is in connecting those choices rather than optimize one independently.

2. The Business He Inherited

Ilan became president and CEO in 2023 after operating roles across Analog and Embedded. TI's October 2025 transition announcement identified his preceding service as COO and made his chairman appointment effective in January 2026. [S26]

He inherited an established manufacturing strategy, not a blank decision about whether factories mattered. The more immediate task was to execute a large program while customer demand and inventory moved through a cycle. Some of the potential advantage and some of the near-term burden had already been committed.

3. Business Thesis

The stated model joins long-lived products, broad customer reach and internal process technology. Better availability can support confidence; more selected devices can create manufacturing demand; qualified internal production can improve lifetime economics. [S7]

The links are conditional. Products can lose technical relevance, capacity may not match the demanded mix and customers may prefer alternatives. Ilan's execution problem is to make the proposed system operate rather than assume the advantages follow from their names.

4. Strategic Bets

Converting construction into productive capability

Sherman SM1 began production in December 2025. The milestone moves part of the program from construction toward operating supply, but does not establish the site's eventual scale or utilization. [S24]

The next decisions concern tools, product routes, yields and demand timing. A completed building and an attractive lifetime investment return are separate achievements.

Extending Embedded through wireless

TI's February 2026 Silicon Labs agreement proposed broader wireless capability, supported by TI's customer reach and internal manufacturing. The deal remained pending at the research cutoff. [S35][S36]

The proposal would add financing, integration and customer-continuity tasks alongside the factory program. It is not just another product launch within an unchanged company boundary.

5. How These Choices Change the Business

More internal capacity changes the balance between outside manufacturing dependence and TI's fixed costs. The direct channel increases access to customer information while making TI responsible for more service execution.

If completed, Silicon Labs would add products and software that need maintained roadmaps and qualified production routes. The intended benefit is more useful participation in embedded designs, not simply a larger combined catalog. Ownership would start that work rather than finish it.

6. Resource Allocation

product and software R&D + process, equipment and factory investment + inventory and customer service + acquisition funding if completed ↓ competitive supply and future operating cash ↓ reinvestment and shareholder distributions

These uses compete. A cash acquisition, factory equipment and shareholder returns cannot all be treated as free consequences of a strategy. The board, CFO and operating teams also participate; the CEO is not the sole author of every capital decision.

TI's cash-flow reconciliation helps distinguish operating cash, capex and incentive proceeds. That separation is important when assessing whether improved cash reflects demand, the spending schedule or another component. [S4][S47]

7. Business Model Before and After

Starting positionDirection being executedOutstanding test
Broad semiconductor catalogMore internally supported supplyActual demand, mix and utilization
Established customer channelDeeper engineering relationshipsUseful service and incremental design positions
Existing wireless productsProposed Silicon Labs expansionClosing, integration and returns

The table describes a mechanism, not an assertion that Ilan invented each element. The strategy spans leadership tenures.

8. What Has Worked and What Remains Unfinished

SM1's production milestone is evidence that a construction project became operating infrastructure. It is not yet proof of the full return on the investment. Likewise, a signed acquisition supplies strategic direction without establishing realized synergies. [S24][S35]

The continuing questions concern customer selection, supply performance and the capacity to support all cash commitments. Weakness in one area would challenge execution without automatically disproving every part of the model. A strong quarter alone would not settle those longer-term questions either.

9. Business Legacy

Ilan's legacy is still forming. The structural test is whether TI can preserve patient product and manufacturing economics while handling a demanding period of capacity deployment and possible integration.

An enduring contribution would be an operating organization that uses customer evidence to guide product and factory choices reliably. That cannot be reduced to one headline launch or one movement in the stock price.

Career Background

His experience across the two major semiconductor businesses matters because analog process decisions and embedded software-platform decisions are not identical. The company needs both, supported by manufacturing and customer execution. [S25][S26]

Common Misconceptions

Ilan personally created every manufacturing decision

The program extends across leadership tenures. His role is execution and adaptation, not sole authorship of the entire history.

Silicon Labs is already included in TI's operating results

At the cutoff it remained a pending transaction. Intended benefits were not consolidated target-company performance. [S36]

Evidence

Related Entities